Furthermore, functional assays revealed that SPATA18 downregulation partially restored cell proliferation and viability in BMN673-treated ATM-deficient CRC cells (Fig. S4e-g), underscoring the significance of mitophagy in mediating the antitumor effects of BMN673. The gene discussed is SPATA18; the disease is colorectal carcinoma.